Current Problems in Cardiology
Volume 31, Issue 11 , Pages 711-760 , November 2006

Endovascular Treatment of Peripheral Vascular Disease

References 

  1. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317–1324
  2. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation. 1996;94:3026;-
  3. Cook JP, Ma AO. In: Ouriel K, editor. Lower extremity vascular disease. 95.
  4. Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med. 2000;109:523–530
  5. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–453
  6. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study (ACAS). Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421–1428
  7. Biller J, Feinberg WM, Castaldo JE, et al. Guidelines for carotid endarterectomy (AHA scientific statement). Circulation. 1998;97:501–509
  8. Diethrich EB, Ndiaye M, Reid DB. Stenting in the carotid artery: initial experience in 110 patients. J Endovasc Surg. 1996;3:42–62
  9. Yadav JS, Roubin GS, Iyer S, et al. Elective stenting of the extracranial carotid arteries. Circulation. 1997;95:376–381
  10. Gupta A, Bhatia A, Ahuja A, Shalev Y, Bajwa T. Carotid stenting in patients older than 65 years with inoperable carotid artery disease: a single-center experience. Cathet Cardiovasc Interv. 2000;50:1–8
  11. Wholey MH, Jarmolowski CR, Eles G, Levy D, Buecthel J. Endovascular stents for carotid artery occlusive disease. J Endovasc Surg. 1997;4:326–338
  12. Shawl F, Kadro W, Domanski MJ, et al. Safety and efficacy of elective carotid artery stenting in high-risk patients. J Am Coll Cardiol. 2000;35:1721–1728
  13. Reimers B, Corvaja N, Moshiri S, et al. Cerebral protection with filter devices during carotid artery stenting. Circulation. 2001;104:12–15
  14. Wholey MH, Wholey M, Mathias K, et al. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv. 2000;50:160–167
  15. Henry M, Henry I, Klonaris C, et al. Benefits of cerebral protection during carotid stenting with the PercuSurge GuardWire system: midterm results. J Endovasc Ther. 2002;9:1–13
  16. Al-Mubarak N, Colombo A, Gaines PA, et al. Multicenter evaluation of carotid artery stenting with a filter protection system. J Am Coll Cardiol. 2002;39:841–846
  17. Whitlow PL, Lylyk P, Londero H, et al. Carotid artery stenting protected with an emboli containment system. Stroke 200;33:1308-14.
  18. Yadav JS, Wholey MH, Kuntz RE, et al. Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators Protected carotid-artery stenting versus endarterectomy in high risk patients. N Engl J Med. 2004;351:1493–1501
  19. Berguer R, Flynn LM, Kline RA, Caplan L. Surgical reconstruction of the extracranial vertebral artery: management and outcome. J Vasc Surg. 2000;31:9–18
  20. Jenkins JS, White CJ, Ramee SR, et al. Vertebral artery stenting. Catheter Cardiovasc Interv. 2001;54:1–5
  21. Malek AM, Higashida RT, Phatouros CC, et al. Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement. Stroke. 1999;30:2073–2085
  22. Beebe HG, Stark R, Johnson ML, Jolly PC, Hill LD. Choices of operation for subclavian vertebral arterial disease. Am J Surg. 1980;139:616–623
  23. Hadjipetrou P, Cox S, Piemonte T, et al. Percutaneous revascularization of atherosclerotic obstruction of aortic arch vessels. J Am Coll Cardiol. 1999;33:1238–1245
  24. Rodriguez-Lopez JA, Werner A, Martinez R, et al. Stenting for atherosclerotic occlusive disease of the subclavian artery. Ann Vasc Surg. 1999;13:254–260
  25. Al-Mubarak N, Liu MW, Dean LS, et al. Immediate and late outcomes of subclavian artery stenting. Cathet Cardiovasc Intervent. 1999;46:169–172
  26. Jain SP, Zhang SY, Khosla S, et al. Subclavian and innominate arteries stenting: acute and long term results. J Am Coll Cardiol. 1998;31:63A
  27. Jean WJ, Al-bitar I, Zwicke DL, et al. High incidence of renal artery stenosis in patients with coronary artery disease. Cathet Cardiovasc Intervent. 1994;32:8;-
  28. Caps MT, Perissinotto C, Zierler RE, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation. 1998;98:2866;-
  29. Caps MT, Zierler RE, Polissar NL, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998;53:735–742
  30. Hansen KJ, Starr SM, Sands RE, et al. Contemporary surgical management of renovascular disease. J Vasc Surg. 1991;16:319;-
  31. Kidney D, Deutsch LS. The indications and results of percutaneous transluminal angioplasty and stenting in renal artery stenosis. Semin Vasc Surg. 1996;9:188–197
  32. Lederman RJ, Mendelsohn FO, Santos R, et al. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J. 2001;142:314–323
  33. Burket MW, Cooper CJ, Kennedy DJ, et al. Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am Heart J. 2000;139:64–71
  34. Rodriguez-Lopez JA, Werner A, Ray LI, et al. Renal artery stenosis treated with stent deployment: indications, technique, and outcome for 108 patients. J Vasc Surg. 1999;29:617–624
  35. Rocha-Singh KJ, Mishkel G, Katholi RE, et al. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis. Cathet Cardiovasc Intervent. 1999;47:167–172
  36. Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation. 1998;98:642–647
  37. White CJ, Ramee SR, Collins TJ, et al. Renal artery stent placement: utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol. 1997;30:1445–1450
  38. Allaqaband S, Shaikh F, Zaidi S, et al. Blood pressure control after renal artery stenting in 100 consecutive hypertensive patients with atherosclerotic renal artery stenosis. Am J Cardiol. 2003;92:53L;(117A)
  39. Dorros G, Jaff M, Mathiak L, et al. Multicenter palmaz stent renal artery stenosis revascularization registry report: four-year follow-up of 1,058 successful patients. Cathet Cardiovasc Intervent. 2002;55:182–188
  40. Dorros G, Jaff M, Rosenfield K ASPIRE-2 Trial Investigators. Evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: the ASPIRE-2 study. J Am Coll Cardiol. 2005;46:776–783
  41. Henry M, Klonaris C, Henry I, et al. Protected renal stenting with the PercuSurge GuardWire device: a pilot study. J Endovasc Ther. 2001;8:227–237
  42. Peripheral Arterial Disease: ACC/AHA 2005 Guidelines for the Management of Patients With (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report From the AAVS/SVS, SCAI, SVMB, SIR, and the ACC/AHA Task Force on Practice Guidelines. www.acc.org
  43. Brewster DC. Direct reconstruction for aortoiliac occlusive disease. In:  Rutherford RB editors. Vascular Surgery. Philadelphia, PA: WB Saunders; 1995;p. 766–794
  44. Tegtmeyer CJ, Kellum CD, Kron IL, et al. Percutaneous transluminal angioplasty in the region of the aortic bifurcation (The two-balloon technique with results and long-term follow-up study). Radiology. 1985;157:661–665
  45. Insall RI, Loose HW, Chamberlain J. Long-term results of double balloon percutaneous transluminal angioplasty of the aorta and iliac arteries. Eur J Vasc Surg. 1993;7:31;-
  46. Vorwerk D, Gunther RW, Schurmann K, et al. Aortic and iliac stenoses: follow-up results of stent placement after insufficient balloon angioplasty in 118 cases. Radiology. 1996;198:45–48
  47. Martinez R, Rodriguez-Lopez J, Diethrich EB. Stenting for abdominal aortic occlusive disease: long-term results. Tex Heart Inst J. 1997;24:15–22
  48. Mendelsohn FO, Santos RM, Crowley JJ, et al. Kissing stents in the aortic bifurcation. Am Heart J. 1998;136:600–605
  49. Haulon S, Mounier-Vehier C, Gaxotte V, et al. Percutaneous reconstruction of the aortoiliac bifurcation with the “kissing stents” technique: long-term follow-up in 106 patients. J Endovasc Ther. 2002;9:363–368
  50. Mouanoutoua M, Allaqaband S, Bajwa T, et al. Endovascular intervention of aortoiliac occlusive disease in high-risk patients using kissing stents technique: Long-term results. Catheter Cardiovas Interv. 2003;60:320–326
  51. Ameli FM, Stein M, Provan JL, et al. Predictors of surgical outcome in patients undergoing aortobifemoral bypass reconstruction. J Cardiovasc Surg. 1990;30:333–339
  52. Johnson KW, Rae M, Hogg-Johnston SA, et al. 5-year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg. 1987;206:403;-
  53. Vorwerk D, Guenther RW, Schurmann K, et al. Primary stent placement for chronic iliac artery occlusions: follow-up results in 103 patients. Radiology. 1995;194:745–749
  54. Bosch JL, Hunink MG. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology. 1997;204:87;-
  55. Vorwerk D, Gunther RW, Schurmann K, et al. Aortic and iliac stenoses: follow-up results of stent placement after insufficient balloon angioplasty in 118 cases. Radiology. 1996;198:45;-
  56. Palmaz JC, Laborde JC, Rivera FJ, et al. Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial. Cardiovasc Intervent Radiol. 1992;15:291–297
  57. Scheinert D, Schroder M, Ludwig J, et al. Stent-supported recanalization of chronic iliac artery occlusions. Am J Med. 2001;110:708–715
  58. Hunink MGM, Wong JB, Donaldson MC, et al. Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease. Med Decis Making. 1994;14:71–81
  59. Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled. Lancet. 2005;366:1925–1934
  60. Pekka JM, Hannu IM, Ritva LV, et al. Femoropopliteal angioplasty in patients with claudication: primary and secondary patency in 140 limbs with 1-3 year follow-up. Radiology. 1994;191:727–733
  61. Johnson KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology. 1992;183:767–771
  62. Capek P, McLean GK, Berkowitz HD. Femoropopliteal angioplasty factors influencing long-term success. Circulation. 1991;83:70–80
  63. Sapoval MR, Long AL, Raynaud AC, et al. Femoropopliteal stent placement: long-term results. Radiology. 1992;184:833–839
  64. Henry M, Amor M, Henry I, et al. Femoropopliteal stenting–results, indications: choice of the stent. Radiology. 1999;213(P):50
  65. Kazemi S, Tumuluri R, Allaqaband S, et al. Percutaneous revascularization of femoropopliteal arteries with self-expanding nitinol stents—immediate success and one-year results. J Am Coll Cardiol. 2005;3(suppl 1):68A
  66. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106:1505;-
  67. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II Trial. J Vasc Interv Radiol. 2005;16:331–338
  68. Lammer J, Dake MD, Bleyn J, et al. International Trial Study Group Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding tent-graft. Radiology. 2000;217:95–104
  69. Kazemi S, Djelmami-Hani AA, Gupta A, et al. Intermediate patency rate of the Viabahn stent-graft for chronic total occlusion or long high-grade stenosis of the superficial femoral artery. Am J Cardiol. 2005;96(suppl 7A):141H
  70. Veith FJ, Gupta SK, Ascer E, et al. Improved strategies for secondary operations on infrainguinal arteries. Ann Vasc Surg. 1990;4:85;-
  71. Ascer E, Collier P, Gupta SK, et al. Reoperation for polytetrafluoroethylene bypass failure: the importance of distal outflow site and operative technique in determining outcome. J Vasc Surg. 1987;5:298–310
  72. Veith FJ, Gupta SK, Wengerter KR, et al. Changing arteriosclerotic disease patterns and management strategies in lower-limb threatening ischemia. Ann Surg. 1990;212:412;-
  73. Dorros G, Jaff MR, Dorros AM, et al. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation. 2001;104:2057;-
  74. Shalev Y, Fortsas MJ, Schmidt DH, et al. A modification of the peripheral angioplasty procedure to treat below-the-knee vascular disease: initial success and late outcome in 97 patients. J Am Coll Cardiol. 1996;29:191A
  75. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol. 2004;44:2307–2314
  76. Clouse WD, Hallett JW, Schaff HV, et al. Improved prognosis of thoracic aortic aneurysms: a population based study. JAMA. 1998;280:1926–1929
  77. Bickerstaff LK, Pairolero PC, Hollier LH, et al. Thoracic aortic aneurysms: a population based study. Surgery. 1982;92:1103–1108
  78. Crawford ES, DeNatale RW. Thoracoabdominal aortic aneurysm: observations regarding the natural course of disease. J Vasc Surg. 1986;3:578–582
  79. Coady MA, Rizzo JA, Hammond GL, et al. Surgical intervention criteria for thoracic aortic aneurysms: a study of growth rates and complications. Ann Thorac Surg. 1999;67:1922–1926
  80. Davies RR, Goldstein LJ, Coady MA, et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: simple prediction based on size. Ann Thorac Surg. 2002;73:17–27
  81. Glade GJ, Vahl W, Wisselink MA, et al. Mid-term survival and costs of treatment of patients with descending thoracic aortic aneurysm; endovascular vs open repair: a case control study. Eur J Vasc Endovasc Surg. 2005;29:28–34
  82. Volodos NL, Karpovich IP, Troyan VI, et al. Clinical experience of the use of self-fixing synthetic prostheses for remote endoprosthetics of the thoracic and the abdominal aorta and iliac arteries through the femoral artery and as intraoperative endoprosthesis for aorta reconstruction. Vasa. 1991;33(suppl):93;-
  83. Thompson CS, Gaxotte VD, Rodriguez JA, et al. Endoluminal stent grafting of the thoracic aorta: initial experience with the Gore Excluder. J Vasc Surg. 2002;35:1163–1170
  84. Makaroun MS, Dillavou ED, Kee ST, et al. Endovascular treatment of thoracic aortic aneurysms: results of the phase II multicenter trial of the GORE TAG thoracic endoprosthesis. J Vasc Surg. 2005;41:1–9
  85. Hodges TC, Cronenwett J. Abdominal aortic and iliac artery aneurysms: clinical presentation, natural history, and indications for intervention. In:  Perler BA,  Becker GJ editor. Vascular Intervention: A Clinical Approach. New York: Thieme; 1998;p. 339;-
  86. Kaufman JA, Geller SC, Brewster DC, et al. Endovascular repair of abdominal aortic aneurysms: current status and future directions. AJR Am J Roentgenol. 2000;175:289–302
  87. Nevitt MP, Ballard DJ, Hallett JW. Prognosis of abdominal aortic aneurysms (A population-based study). N Engl J Med. 1989;321:1009–1014
  88. Hallett JW. Management of abdominal aortic aneurysms. Mayo Clin Proc. 2000;75:395–399
  89. Hollier LH, Taylor LM, Ochsner J. Recommended indications for operative treatment of abdominal aortic aneurysms: report of a subcommittee of the Joint Council of the Society for Vascular Surgery and the International Society for Cardiovascular Surgery. J Vasc Surg. 1992;15:1046–1056
  90. Hallett JW, Marshall DM, Petterson TM, et al. Graft-related complications after abdominal aortic aneurysm repair: reassurance from a 36-year population-based experience. J Vasc Surg. 1997;25:277–286
  91. Johnston KW Canadian Society for Vascular Surgery Aneurysm Study Group. Nonruptured abdominal aortic aneurysm: six-year follow-up results from the multicenter prospective Canadian aneurysm study. J Vasc Surg. 1994;20:163–170
  92. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg. 1991;5:491–499
  93. Zarins CK, White RA, Moll FL, et al. The AneuRx stent graft: four-year results and worldwide experience 2000. J Vasc Surg. 2001;33:S135–S145
  94. Buth J, van Marrewijk CJ, Harris PL, et al. Outcome of endovascular abdominal aortic aneurysm repair in patients with conditions considered unfit for an open procedure: a report on the EUROSTAR experience. J Vasc Surg. 2002;35:211–221
  95. May J, White GH, Waugh R, et al. Improved survival after endoluminal repair with second-generation prostheses compared with open repair in the treatment of abdominal aortic aneurysms: a 5-year concurrent comparison using life table method. J Vasc Surg. 2001;33(suppl 2):S21–S26
  96. Zarins CK AneuRx Clinical Investigators. The US AneuRx Clinical Trial: 6-year clinical update 2002. J Vasc Surg. 2003;37:904–908
  97. Harris PL, Buth J. An update on the important findings from the EUROSTAR EVAR registry. Vascular. 2004;12:33–38
  98. EVAR trial participants. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet. 2005;365:2179–2186
  99. EVAR trial participants. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet. 2005;65:2187–2192
  100. Prinssen M, Verhoeven EL, Buth J, et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2004;351:1607–1618
  101. Blankensteijn JD, de Jong SE, Prinssen M, et al. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med. 2005;352:2398–2405
  102. Nachbur BH, Inderbitzi RG, Bar W. Isolated iliac aneurysms. Eur J Vasc Surg. 1991;5:375–381
  103. Richardson JW, Greenfield LJ. Natural history and management of iliac aneurysms. J Vasc Surg. 1988;8:165;-
  104. Scheinert D, Schroder M, Steinkamp H, et al. Treatment of iliac artery aneurysms by percutaneous implantation of stent grafts. Circulation. 2000;102:III-253-8
  105. Sahgal A, Veith F, Lipsitz E, et al. Diameter changes in isolated iliac artery aneurysms 1 to 6 years after endovascular graft repair. J Vasc Surg. 2001;33:289–295
  106. Trickett JP, Scott RAP, Tilney HS. Screening and management of asymptomatic popliteal aneurysms. J Med Screen. 2002;9:92–93
  107. Thompson MM, Sayers RD. Arterial Aneurysms. Companion to Specialist Surgical Practice, Vol. VII. Arterial Surgery. London: WB Saunders; 1998;
  108. Dawson I, Sie RB, van Bockel JH. Atherosclerotic popliteal aneurysm. Br J Surg. 1997;84:293–299
  109. Michaels JA, Galland RB. Management of asymptomatic popliteal aneurysms: the use of a Markov decision tree to determine the criteria for a conservative approach. Eur J Vasc Surg. 1993;7:136;-
  110. Tielliu IFJ, Verhoeven ELG, Prins TR, et al. Treatment of popliteal artery aneurysms with the Hemobahn stent-graft. J Endovasc Ther. 2003;10:111–116
  111. Markman M. Diagnosis and management of superior vena cava syndrome. Cleve Clin J Med. 1999;66:59–61
  112. Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database of Systematic Reviews. 2002;(4):CD001316
  113. Charnsangavej C, Carrasco C, Wallace S, et al. Stenosis of the vena cava: preliminary assessment of treatment with expandable metallic stent. Radiology. 1986;161:295–298
  114. Mathias K, Jager H, Willaschek J, et al. Interventional radiology in central venous obstructions (Dilatation–stent implantation–thrombolysis). Radiologe. 1998;38:606–613
  115. Sunder SK, Ekong EA, Sivalingam K, et al. Superior vena cava thrombosis due to pacing electrodes: successful treatment with combined thrombolysis and angioplasty. Am Heart J. 1992;123:790–792
  116. Lanciego C, Chacon JL, Julian A, et al. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. AJR Am J Roentgenol. 2001;177(3):585;-
  117. Nordstrom M, Linblad B, Bergqvist D, et al. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med. 1992;232:155–160
  118. Anderson FA, Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case fatalities of deep vein thrombosis and pulmonary embolism (The Worcester DVT study). Arch Intern Med. 1991;151:933–938
  119. Bergqvist D, Jendteg S, Johansen L, et al. Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med. 1997;126:454–457
  120. Ziegler S, Schillinger M, Maca TH, et al. Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago. Thromb Res. 2001;101:23–33
  121. Elliot MS, Immelman EJ, Jeffery P, et al. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: an interim report of a prospective trial. Br J Surg. 1979;66:838–843
  122. Arnesen H, Høiseth A, Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis: follow-up results of a prospective study. Acta Med Scand. 1982;211:65;-
  123. Meissner MH, Manzo RA, Bergelin RO, et al. Deep venous insufficiency: the relationship between lysis and subsequent reflux. J Vasc Surg. 1993;18:596–605discussion, 606-8
  124. Meyerovitz MF, Polak JF, Goldhaber SZ. Short-term response to thrombolytic therapy in deep venous thrombosis: predictive value of venographic appearance. Radiology. 1992;184:345–348
  125. Comerota A, Aldridge S. Thrombolytic therapy for acute deep venous thrombosis. Semin Vasc Surg. 1992;5:76;-
  126. Schweizer J, Kirch W, Koch R, et al. Short- and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol. 2000;36:1336–1343
  127. Semba CP, Dake MD. Iliofemoral deep venous thrombosis: aggressive therapy with catheter-directed thrombolysis. Radiology. 1994;191:487–494
  128. Mewissen MW, Seabrook GR, Meissner MH, et al. Catheter-directed thrombolysis of lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39;-
  129. Ouriel K, Gray B, Clair DG, et al. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol. 2000;11:295;-
  130. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep vein thrombosis. N Engl J Med. 1998;338:409;-
  131. Kucher N, Rossi E, De Rosa M, et al. Massive pulmonary embolism. Circulation. 2006;113:577–582
  132. Ouriel K. Surgery versus thrombolytic therapy in the management of peripheral arterial occlusions. J Vasc Interv Radiol. 1995;6:48S–54S
  133. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity: The STILE trial. Ann Surg. 1994;220:251–268
  134. Ouriel K, Veith FJ, Sasahara AA. Thrombolysis or peripheral arterial surgery (TOPAS): phase I results. J Vasc Surg. 1996;23:64–73
  135. Ouriel K, Veith FJ, Sasahara AA Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N Engl J Med. 1998;338:1105–1111
  136. Pilger E, Decrinis M, Stark G, et al. Thrombolytic treatment and balloon angioplasty in chronic occlusion of the aortic bifurcation. Ann Intern Med. 1994;120:40–44
  137. Silva JA, Ramee SR, Collins TJ, et al. Possis Peripheral AngioJet Study AngioJet Investigators Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: immediate results and six-month follow-up of the multicenter AngioJet registry. Cathet Cardiovasc Diagn. 1998;45:386–393
  138. Wagner HJ, Mueller-Huelsbeck S, Pitton MB, et al. Rapid thrombectomy with a hydrodynamic catheter: results from a prospective, multicenter trial. Radiology. 1997;205:675–681

 The authors have no conflict of interests to disclose.

PII: S0146-2806(06)00100-9

doi: 10.1016/j.cpcardiol.2006.08.002

Current Problems in Cardiology
Volume 31, Issue 11 , Pages 711-760 , November 2006

Article Tools

* Image Usage & Resolution